Kwality Pharmaceuticals P/E Ratio

KPL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
26.74
High Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 26.74
Current Price ₹1424.05
EPS (TTM) ₹38.36
Exchange BSE

Valuation Signal

Signal Overvalued
Historical Avg 20.49
Historical Range 10.67 - 30.44
Percentile 66.7%

Sector Context

Sector Average 47.31
Sector Median 25.62
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹54.46
Sept 2025 ₹13.60
Mar 2025 ₹13.95

Key P/E Ratio Insights for Kwality Pharmaceuticals

  • Stock appears overvalued with PE of 26.74, suggesting caution for new investments
  • Current PE is 30.5% above historical average
  • Trading at discount to sector average PE of 47.31

P/E Ratio Historical Trend for Kwality Pharmaceuticals

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 20.35 54.46 ₹1108.35 BSE Moderate
2024 30.44 28.48 ₹866.80 BSE High
2022 10.67 35.6 ₹379.80 BSE Low

Sector P/E Ratio Comparison

Comparing Kwality Pharmaceuticals with other companies in Healthcare sector
Sector Average
47.31
Sector Median
25.62
Lowest P/E
0.9
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.9 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.48 ₹1,128 Low
Amwill Health Care AMWILL 5.98 ₹61 Low
Medicamen Organics MEDIORG 6.37 ₹25 Low
Brooks Laboratories BROOKS 6.41 ₹127 Low
Unichem Laboratories UNICHEMLAB 7.14 ₹2,000 Low
Zenith Drugs ZENITHDRUG 7.28 ₹65 Low
Galaxy Medicare GML 7.77 ₹26 Low
Vasundhara Rasayans VRL 9.19 ₹34 Low